![]() |
市场调查报告书
商品编码
1684551
乳房植入物组织扩张器市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测Breast Implant Tissue Expanders Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球乳房植入物组织扩张器市场价值为 7.041 亿美元,并将经历强劲成长,2025 年至 2034 年的复合年增长率为 6.1%。组织扩张器是关键的医疗设备,在为乳房重建或增大准备皮肤和软组织方面发挥重要作用。这些装置主要用于乳房切除术后、创伤后或治疗先天性畸形。
随着人们对乳房重建的关注度不断提高,特别是乳癌倖存者,以及整容手术需求的不断增加,市场正在经历大幅增长。此外,新兴经济体的认识不断提高和手术选择的可及性改善也极大地促进了这一上升趋势。组织扩张器设计技术的进步也支持了这一成长,确保了患者获得更大的舒适度、安全性和满意度。如今,越来越多的患者选择手术,不仅能满足医疗需求,还能改善美观,进而进一步推动市场的发展。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 7.041亿美元 |
预测值 | 13亿美元 |
复合年增长率 | 6.1% |
根据产品类型,市场分为硅胶扩张器和盐水扩张器,其中硅胶基扩张器预计将保持稳定的成长轨迹。硅胶扩张器市场预计将以 6.3% 的复合年增长率扩张,到 2034 年市值将达到 9.253 亿美元。硅胶扩张器因其与人体组织极为相似而备受青睐,使其成为重建和美容用途的理想选择。它们的柔软度、耐用性以及模仿乳房组织自然感觉的能力使它们在患者中越来越受欢迎,从而导致需求不断上升,特别是在人们对手术选择的认识日益增强的新兴市场。
从应用角度来看,市场分为隆乳、乳房切除术后重建等用途。 2024 年,乳房切除术后重建部分占了最大的份额,为 65.5%。随着全球乳癌发生率的持续上升,越来越多的女性接受乳房切除术,这增加了透过重建手术恢復乳房形状和结构的需求。这一领域的成长不仅是由医疗需求推动的,而且还受到这些手术对乳癌倖存者带来的心理和情感益处的推动,使其成为乳癌治疗的一个重要方面。
2024 年美国乳房植入物组织扩张器市场价值为 2.208 亿美元,并将持续成长。美国拥有最多的专注于乳房重建的专业整形外科医生,这使其成为组织扩张器的主要市场。作为全球最大的整容手术市场,尤其是隆乳手术市场,组织扩张器的需求正在上升。此外,美国市场受益于对客製化、符合人体解剖学形状的硅胶扩张器的日益增长的偏好,为患者提供更自然的效果。这些因素,再加上组织扩张器在分阶段隆乳手术中的整合,进一步推动了美国市场的成长,确保了其在全球市场继续占据主导地位。
The Global Breast Implant Tissue Expanders Market was valued at USD 704.1 million in 2024 and is set to experience robust growth, with a CAGR of 6.1% from 2025 to 2034. Tissue expanders are critical medical devices that play an essential role in preparing the skin and soft tissue of the breast for reconstruction or augmentation. These devices are predominantly used after mastectomy, trauma, or to address congenital deformities.
With the increasing focus on breast reconstruction, particularly among breast cancer survivors, and rising cosmetic surgery demand, the market is witnessing substantial growth. Moreover, expanding awareness and improved accessibility to surgical options in emerging economies contribute significantly to this upward trend. This growth is also supported by technological advancements in tissue expander design, ensuring greater patient comfort, safety, and satisfaction. Patients today are increasingly opting for surgeries that not only address medical needs but also enhance their aesthetic appearance, further propelling the market forward.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $704.1 Million |
Forecast Value | $1.3 Billion |
CAGR | 6.1% |
The market is categorized by product type into silicone and saline expanders, with silicone-based expanders projected to maintain a steady growth trajectory. The silicone expander segment is expected to expand at a CAGR of 6.3%, reaching a market value of USD 925.3 million by 2034. Silicone expanders are highly favored due to their superior resemblance to human tissue, making them ideal for both reconstructive and cosmetic purposes. Their softness, durability, and ability to mimic the natural feel of breast tissue have made them increasingly popular among patients, leading to rising demand, particularly in emerging markets where awareness of surgical options is growing.
When looking at applications, the market is divided into breast augmentation, post-mastectomy reconstruction, and other uses. The post-mastectomy reconstruction segment accounted for the largest share of 65.5% in 2024. With the ongoing rise in breast cancer incidences worldwide, more women are undergoing mastectomy procedures, which increases the need for reconstructive surgeries to restore breast shape and structure. This segment's growth is not only driven by medical necessity but also by the psychological and emotional benefits these surgeries offer to breast cancer survivors, making it an essential aspect of breast cancer treatment.
The U.S. breast implant tissue expander market is valued at USD 220.8 million in 2024 and continues to experience growth. The U.S. has the largest concentration of specialized plastic surgeons focusing on breast reconstruction, making it a key market for tissue expanders. As the world's largest market for cosmetic surgeries, particularly breast augmentation, the demand for tissue expanders is on the rise. Additionally, the U.S. market benefits from an increasing preference for customized and anatomically shaped silicone expanders, offering patients more natural-looking outcomes. These factors, coupled with the integration of tissue expanders in staged breast augmentation surgeries, are further fueling the growth of the U.S. market, ensuring its continued dominance in the global landscape.